H3C Technologies H3C SecPath F1000-A-EI - Handbuch (Seite 3)

i
Table of Contents
1 Safety Information Sicherheits informationen安全信息 ·········································································1-1
Overview Überblick 概述 ·························································································································1-1
Conventions Used Symbole Erläuterung应用惯例··········································································1-2
Important Safety Information/Wichtige Sicherheitshinweise/重要安全信息 ····································1-3
Electricity Safety Elektrische Sicherheit 用电安全 ··················································································1-7
High Voltage Hochspannung高电压································································································1-7
Thunderstorm Gewitter 防雷击········································································································1-9
Lithium Battery Lithiumbatterie 锂电池····································································································1-9
2 Regulatory Compliance Information········································································································2-1
Regulatory compliance standards···········································································································2-1
European Directives compliance ············································································································2-2
LVD/EMC Directive··························································································································2-2
WEEE Directive–2002/96/EC ··········································································································2-2
USA regulatory compliance ····················································································································2-2
FCC Part 15·····································································································································2-2
FDA··················································································································································2-3
Canada regulatory compliance ···············································································································2-3
ICES-003 ·········································································································································2-3
Japan regulatory compliance ··················································································································2-3
VCCI ················································································································································2-3
CISPR 22 compliance ·····························································································································2-3
CCC Class A声明····································································································································2-3